CHENGDA PHARMA released its first-quarter performance, turning from profit to a loss of 1.4 million yuan
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, CHENGDA PHARMA released its first-quarter report for 2025, reporting an operating income of 76.3078 million yuan, a year-on-year decrease of 24.37%. The net loss attributable to shareholders of the listed company was 1.4 million yuan. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 5.8541 million yuan. The basic loss per share was 0.0092 yuan
According to the Zhitong Finance APP, CHENGDA PHARMA (301201.SZ) released its first quarter report for 2025, showing an operating income of 76.3078 million yuan, a year-on-year decrease of 24.37%. The net loss attributable to shareholders of the listed company was 1.4 million yuan. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 5.8541 million yuan. The basic loss per share was 0.0092 yuan